Product peptide-Inhibitory-peptide

Home > products > peptide> Inhibitory-peptide

Catalog	name	Description	price
R-R-1034	Diprotin A TFA	Diprotin A TFA (Ile-Pro-Ile TFA)/CAS No.209248-71-5 is an inhibitor of dipeptidyl peptidase IV (DPP-IV).	price>
R-R-1035	Irucalantide	Irucalantide/CAS No.1631160-47-8 is kallikrein inhibitor.	price>
R-R-1037	Valinomycin	Valinomycin (NSC 122023)/CAS No.2001-95-8, a cyclic depsipeptide antibiotic, act as a potassium selective ionophore. Valinomycin (NSC 122023) inhibits lymphocyte proliferation by its effects on the cell membrane, and induces apoptosis in CHO cells. Valinomycin induces activation of PINK1 leading to Parkin Ser65 phosphorylation.	price>
R-R-1059	Tat-NR2B9c TFA	Tat-NR2B9c TFA (Tat-NR2Bct TFA)/CAS No.1834571-04-8 is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c TFA disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c TFA also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy.	price>
R-R-1060	Tat-NR2B9c CAS.500992-11-0	Tat-NR2B9c (Tat-NR2Bct; NA-1)/CAS.500992-11-0 is a postsynaptic density-95 (PSD-95) inhibitor, with EC50 values of 6.7 nM and 670 nM for PSD-95d2 (PSD-95 PDZ domain 2) and PSD-95d1, respectively. Tat-NR2B9c disrupts the PSD-95/NMDAR interaction, inhibiting NR2A and NR2B binding to PSD-95 with IC50 values of 0.5 μM and 8 μM, respectively. Tat-NR2B9c also inhibits neuronal nitric oxide synthase (nNOS)/PSD-95 interaction, and possesses neuroprotective efficacy.	price>
R-R-1070	TAT-DEF-Elk-1 TFA	TAT-DEF-Elk-1 TFA (TDE TFA) is a cell-penetrating peptide inhibitor of Elk-1, mimics and specifically interferes with the DEF domain of Elk-1. TAT-DEF-Elk-1 TFA blocks Elk-1 phosphorylation and prevents Elk-1 nuclear translocation without interfering with ERK nor MSK1 activation. TAT-DEF-Elk-1 TFA is a useful tool to analyze the role of Elk-1 in this process during the development of neuronal plasticity.	price>
R-R-1071	Parstatin(mouse) TFA	Parstatin(mouse) TFA, a cell-penetrating PAR-1 thrombin receptor agonist peptide, is a potent inhibitor of angiogenesis.	price>
R-R-1073	PKC β pseudosubstrate	PKC β pseudosubstrate/CAS No.172308-76-8 is a selective cell-permeable inhibitor of PKC.	price>
R-M-188	Protein Kinase C(PKC) [19-35] Peptide	This peptide corresponds to the residues 19-35 of the pseudosubstrate domain of protein kinase C isoforms alpha and beta. The peptide is a potent inhibitor of both the phosphorylation of protein kinase C substrates (Ki = 147 nM) and the autophosphorylation of protein kinase C whereas it has a low inhibitory activity on protein kinase A (IC50 = 423 mM).	price>
R-M-189	PKA Inhibitor [6-22] Peptide	PKA Inhibitor [6-22] Peptide ,protein kinase A Inhibitor [6-22] Peptide from ruixi.This peptide is a potent and competitive inhibitor of protein kinase A (PKA) with a Ki = 1.7 nM. The peptide sequence corresponds to residues 6-22 of human cAMP-dependent protein kinase inhibitor alpha (PKI-alpha) and is amidated at the C-terminus end. PKI-alpha interacts with the catalytic subunit of PKA after the cAMP-induced dissociation of its regulatory chains.	price>

...